Mangas-Sanjuán, V.; Simón, M.; González-Rojano, E.; Ochoa, D.; Abad-Santos, F.; Román, M.; Ramos, M.; Govantes, C.; García-Arieta, A.
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study. Pharmaceutics 2023, 15, 409.
https://doi.org/10.3390/pharmaceutics15020409
AMA Style
Mangas-Sanjuán V, Simón M, González-Rojano E, Ochoa D, Abad-Santos F, Román M, Ramos M, Govantes C, García-Arieta A.
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study. Pharmaceutics. 2023; 15(2):409.
https://doi.org/10.3390/pharmaceutics15020409
Chicago/Turabian Style
Mangas-Sanjuán, Víctor, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, and Alfredo García-Arieta.
2023. "Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study" Pharmaceutics 15, no. 2: 409.
https://doi.org/10.3390/pharmaceutics15020409
APA Style
Mangas-Sanjuán, V., Simón, M., González-Rojano, E., Ochoa, D., Abad-Santos, F., Román, M., Ramos, M., Govantes, C., & García-Arieta, A.
(2023). Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study. Pharmaceutics, 15(2), 409.
https://doi.org/10.3390/pharmaceutics15020409